Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
Journal Title: Journal of Clinical Research and Ophthalmology - Year 2015, Vol 2, Issue 2
Abstract
Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant regarding vascular endothelial growth factor (VEGF) [1].
Authors and Affiliations
Fang-Ting Fang-Ting, Jia-Kang Wang
Keywords
Related Articles
- EP ID EP230589
- DOI 10.17352/2455-1414.000011
- Views 108
- Downloads 0
Hydro-visco-implantation Technique for Wound-assisted Foldable Intraocular Lens Implantation During Microincision Cataract Surgery
We have described a hydro-visco-implantation technique (simultaneous use of sodium hyaluronate and balanced salt solution) for wound-assisted intraocular lens (IOL) implantation and passive removal of ophthalmic viscosur...
Sensory Compensation in Children Following Vision Loss after Trauma and Disease
Sensory compensation or sensory substitution occurs when a sense organ, such as the eye, is lost due to trauma or disease. Individuals often experience phantom limb sensation or pain but research increasingly points towa...
A Laboratory Study on the Molecular Basis of Primary Congenital Glaucoma
Purpose: To detect pathogenic mutations in cytochrome P450 family1 subfamily B polypeptide1 (CYP1B1) gene in nineteen sporadic Primary congenital glaucoma (PCG) cases and to identify patients lacking CYP1B1 mutations. M...
Atypical Presentation of Uveal and Conjunctival Melanoma in the Anterior Segment
Ocular melanoma is a rare malignancy arising from melanocytes of the uvea, the conjunctiva, and the orbit. Uveal melanoma is the most common intraocular malignancy in adults, accounting for 85-95% of ocular melanomas [1-...
Intravitreal Bevacizumab Injection Effect in Exudative Age Related Macular Degeneration
Exudative age-related macular degeneration is the most common cause of vision loss of people over the age 60 in the developed countries. The cause is not clear yet, but since Avastin is largely used for the treatment, th...